Millipore Corporation Signs License Agreement with Astellas
News Dec 05, 2008
Millipore Corporation has announced it has entered into a worldwide, non-exclusive license agreement with Astellas Pharma, Inc. to use Millipore's UCOE™ (Ubiquitous Chromatin Opening Element) technology in its research programs.
The license will enable Astellas to produce its drug targets, such as antibodies in mammalian cells, by generating higher protein yields. Financial terms were not disclosed.
"We value Astellas’ commitment to the UCOE technology," said Andrew Bulpin, Vice President of Millipore's Upstream Bioprocessing Business Unit. "This license is another example of how we can help pharmaceutical and biotech companies efficiently develop biologic drugs."
The process of manufacturing biologic drugs such as monoclonal antibodies and other recombinant proteins often begins with growing mammalian cells in a bioreactor. These cells act as "factories" and produce the proteins that form the basis of biologic drugs.
According to Millipore, its UCOE technology helps biopharmaceutical companies identify which cells will be the most effective in producing proteins during large-scale manufacturing. By isolating these stable and highly productive cell lines, biopharmaceutical manufacturers can improve the yield and consistency of their manufacturing processes. The cost of manufacturing recombinant protein-based drugs makes quick identification of cell lines a critical factor in improving productivity.
Millipore's UCOE technology, which was originally licensed from the laboratory of Dr. Michael Antoniou at King's College, London, can be used for the simple generation of proteins at small scale for drug discovery and research, as well as for identifying stable and highly productive cell lines suitable for larger scale manufacturing.
Habitat loss, habitat fragmentation and the loss of genetic diversity are the main factors driving the extinction of many wild species, and the few eastern massasauga rattlesnakes remaining in Illinois have certainly suffered two of the three. A long-term study of these snakes reveals, however, that – despite their alarming decline in numbers – they have retained a surprising amount of genetic diversity.READ MORE
Researchers have discovered a navigational gene in glass catfish called the electromagnetic-perceptive gene, or EPG, that responds to certain magnetic waves. These findings have the potential to revolutionize treatments for humans and help those who suffer from tremors related to Parkinson’s and seizures associated with epilepsy.